Asset Details
Do you wish to reserve the book?
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
Do you wish to request the book?
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
2021
Overview
Toll-like receptors 3 (TLR3) have been broadly studied among all TLRs over the last few decades together with its agonists due to their contribution to cancer regression. These agonists undeniably have some shared characteristics such as mimicking dsRNA but pathways through which they exhibit antitumor properties are relatively diverse. In this review, three widely studied agonists RGC100, ARNAX, and poly-IC are discussed along with their structural and physiochemical differences including the signaling cascades through which they exert their actions. Comparison has been made to identify the finest agonist with maximum effectivity and the least side effect profile.
We currently cannot retrieve any items related to this title. Kindly check back at a later time.